Smad4-dependent suppressor pituitary homeobox 2 promotes PPP2R2A-mediated inhibition of Akt pathway in pancreatic cancer

The importance of Pituitary homeobox 2 (Pitx2) in malignancy remains enigmatic, and Pitx2 has not been previously implicated in pancreatic ductal adenocarcinoma (PDAC). In this study, we performed gene expression profiling of human PDAC tissues and identified Pitx2 as a promising candidate. Pitx2 expression was decreased from 2.6- to 19-fold in human PDAC tissues from microarray units. Immunochemistry staining showed that Pitx2 expression was moderate to intense in normal pancreatic and pancreatic intraepithelial neoplastic lesions, whereas low in human PDAC tissues. The Pitx2 levels correlated with overall patient survival post-operatively in PDAC. Induction of Pitx2 expression partly inhibited the malignant phenotype of PDAC cells. Interestingly, low Pitx2 expression was correlated with Smad4 mutant inactivation, but not with Pitx2 DNA-methylation. Furthermore, Smad4 protein bound to Pitx2 promoter and stimulated Pitx2 expression in PDAC. In addition, Pitx2 protein bound to the promoter of the protein phosphatase 2A regulatory subunit B55α (PPP2R2A) and upregulated PPP2R2A expression, which may activate dephosphorylation of Akt in PDAC. These findings provide new mechanistic insights into Pitx2 as a tumor suppressor in the downstream of Smad4. And Pitx2 protein promotes PPP2R2A expression which may inhibit Akt pathway. Therefore, we propose that the Smad4-Pitx2-PPP2R2A axis, a new signaling pathway, suppresses the pancreatic carcinogenesis.

[1]  Baoan Ma,et al.  MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1 , 2015, Oncotarget.

[2]  He Jiang,et al.  Exploring the Wnt Pathway-Associated LncRNAs and Genes Involved in Pancreatic Carcinogenesis Driven by Tp53 Mutation , 2015, Pharmaceutical Research.

[3]  L. Paz-Ares,et al.  Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer , 2015 .

[4]  J. Clements,et al.  PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancer , 2014, Clinical & Experimental Metastasis.

[5]  S. Mukhopadhyay,et al.  FGF16 Promotes Invasive Behavior of SKOV-3 Ovarian Cancer Cells through Activation of Mitogen-activated Protein Kinase (MAPK) Signaling Pathway* , 2013, The Journal of Biological Chemistry.

[6]  He Jiang,et al.  The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models. , 2013, Cancer letters.

[7]  Yan Liu,et al.  Cyclin A1 is a transcriptional target of PITX2 and overexpressed in papillary thyroid carcinoma , 2013, Molecular and Cellular Biochemistry.

[8]  C. Arsov,et al.  Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis. , 2013, Urologic oncology.

[9]  He Jiang,et al.  BRCA2 dysfunction promotes malignant transformation of pancreatic intraepithelial neoplasia. , 2013, Anti-cancer agents in medicinal chemistry.

[10]  Sib Sankar Roy,et al.  Wnt/β-Catenin Pathway Is Regulated by PITX2 Homeodomain Protein and Thus Contributes to the Proliferation of Human Ovarian Adenocarcinoma Cell, SKOV-3* , 2012, The Journal of Biological Chemistry.

[11]  J. Hacia,et al.  Fibroblast Growth Factor 9 (FGF9)-Pituitary Homeobox 2 (PITX2) Pathway Mediates Transforming Growth Factor β (TGFβ) Signaling to Regulate Cell Proliferation in Palatal Mesenchyme during Mouse Palatogenesis* , 2011, The Journal of Biological Chemistry.

[12]  R. Hennekam,et al.  Digenic inheritance of mutations in FOXC1 and PITX2 : Correlating transcription factor function and axenfeld‐rieger disease severity , 2011, Human mutation.

[13]  K. Mimori,et al.  The Significance of PITX2 Overexpression in Human Colorectal Cancer , 2011, Annals of Surgical Oncology.

[14]  J. Shea,et al.  Phenotype and Genotype of Pancreatic Cancer Cell Lines , 2010, Pancreas.

[15]  Sheue-yann Cheng,et al.  Pituitary homeobox 2 (PITX2) promotes thyroid carcinogenesis by activation of cyclin D2 , 2010, Cell cycle.

[16]  J. Welti,et al.  Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development , 2009, Development.

[17]  R. Magness,et al.  Suppression of protein phosphatase 2 differentially modulates VEGF- and FGF2-induced signaling in ovine fetoplacental artery endothelial cells. , 2009, Placenta.

[18]  D. Tuveson,et al.  An shRNA silencing a non‐toxic transgene reduces nutrient consumption and increases production of adenoviral vectors in a novel packaging cell , 2009, Journal of cellular physiology.

[19]  G. Kristiansen,et al.  DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy. , 2009, The Journal of urology.

[20]  J. Foekens,et al.  Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  John W. M. Martens,et al.  DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients , 2008, Breast Cancer Research and Treatment.

[22]  W. Lee,et al.  Regulation of Phosphorylation of Thr-308 of Akt, Cell Proliferation, and Survival by the B55α Regulatory Subunit Targeting of the Protein Phosphatase 2A Holoenzyme to Akt* , 2008, Journal of Biological Chemistry.

[23]  H. Buhr,et al.  Epithelial to Mesenchymal Transition: Expression of the Regulators Snail, Slug, and Twist in Pancreatic Cancer , 2007, Clinical Cancer Research.

[24]  R. Hruban,et al.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.

[25]  E. Petricoin,et al.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.

[26]  M. Löhr,et al.  A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform , 2003, Virchows Archiv.

[27]  Paola Briata,et al.  Identification of a Wnt/Dvl/β-Catenin → Pitx2 Pathway Mediating Cell-Type-Specific Proliferation during Development , 2002, Cell.

[28]  M. Tsao,et al.  Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. , 2000, The American journal of pathology.